olivlawolivlaw

olivLaw · US equity research

Lam Research Corporation LRCX

Special Industry Machinery, NEC · SIC 3559 · Vertical: Special Industry Machinery, NEC (SIC 3559)

230.72USD+1.39% · 1 dayClose 03 Nov 2026

Lam Research is a global supplier of wafer fabrication equipment spanning deposition, etch and clean. Revenue in fiscal 2026 reached 23.23 billion USD, up 26.0%, supported by demand linked to artificial intelligence. In the quarter ended September 27, 2026, revenue was 8.22 billion USD.

At the close of 03 Nov 2026, Lam Research Corporation (LRCX) stock was 230.72 USD (+1.39% on the day), with market capitalisation 288.2 bn USD, P/E 34.4 on diluted EPS of 6.71 USD over the last 12 months, dividend yield 0.48%, beta 2.31, 52-week range 139.59–433.33 USD. Latest reported quarter (Q1 2027): revenue of 8.2 bn USD (+54.4% YoY), net income of 2.8 bn USD (+75.5% YoY), diluted EPS 2.19 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
288.2 bn USD
shares as of 20 Oct 2026
P/E (TTM)
34.4
Diluted EPS TTM 6.71 · TTM to 27 Sept 2026
E/P (TTM)
2.91%
TTM to 27 Sept 2026
Dividend yield
0.48%
DPS 12m 1.11
Beta (2y)
2.31
Volatility (1y) 66%
52-week range
139.59433.33

Price history

Loading chart…

Technical reading

RSI (14)
32.5
weak (30–45)
Bollinger (20, 2)
202.18 – 332.68
in the lower half of the band · %B 0.22 · band width 48.8%
SMA 50 / 200
291.15 / 284.33
mixed trend
MACD (12, 26, 9)
-19.56 / -16.86
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month−33.6%−2.0%−31.6 pp—
3 months−27.4%−2.2%−25.2 pp—
6 months−16.3%+4.3%−20.6 pp—
Year to date+34.8%+10.6%+24.2 pp—
1 year+43.1%+10.5%+32.6 pp+19.4%
3 years+263.9%+73.7%+190.2 pp+8.3%
5 years+285.3%+61.7%+223.6 pp—
Max drawdown (1y)
−47.5%
30 Jun 2026 → 02 Nov 2026
Max drawdown (5y)
−56.8%
14 Jan 2022 → 14 Oct 2022
Compound annual growth (5y)
+31.0%
S&P 500 +10.1%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q1 2027 · 27 Sept 2026

Revenue
8.2 bn USD
+54.4% YoY
Net income
2.8 bn USD
+75.5% YoY
Diluted EPS
2.19
+76.6% YoY
net / operating
33.5% / 40.0%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Revenue4.4 bn4.7 bn5.2 bn5.3 bn5.3 bn5.8 bn6.7 bn8.2 bn
Cost of revenue2.3 bn2.4 bn2.6 bn—————
Gross profit2.1 bn2.3 bn2.6 bn2.7 bn2.7 bn2.9 bn3.5 bn4.3 bn
Research & development494.9 m525.9 m580.2 m576.4 m573.3 m583.2 m642.9 m666.4 m
SG&A244.2 m226.0 m268.4 m279.3 m267.7 m280.3 m322.3 m348.7 m
Operating income1.3 bn1.6 bn1.7 bn1.8 bn1.8 bn2.0 bn2.5 bn3.3 bn
Depreciation & amortisation96.2 m ≈97.3 m ≈98.4 m101.6 m103.9 m ≈116.3 m ≈119.6 m122.1 m
Interest expense45.3 m45.2 m42.8 m42.5 m40.9 m39.3 m34.2 m36.8 m
Pre-tax income1.3 bn1.5 bn1.8 bn1.9 bn1.8 bn2.0 bn2.6 bn3.3 bn
Income tax157.1 m206.1 m58.9 m290.5 m242.6 m186.1 m277.9 m559.1 m
Net income1.2 bn1.3 bn1.7 bn1.6 bn1.6 bn1.8 bn2.3 bn2.8 bn
Diluted EPS0.921.031.35 ≈1.241.261.451.81 ≈2.19
Operating cash flow741.9 m ≈1.3 bn ≈2.6 bn1.8 bn1.5 bn ≈1.1 bn ≈1.5 bn3.5 bn
Capex188.3 m ≈288.1 m ≈172.2 m185.1 m260.9 m ≈331.6 m ≈188.8 m257.7 m
Dividends paid297.6 m ≈295.7 m ≈295.2 m292.0 m327.5 m ≈325.8 m ≈325.3 m325.4 m
Share repurchases697.7 m ≈435.3 m ≈1.3 bn975.8 m1.5 bn ≈1.2 bn ≈246.6 m1.0 bn

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 86 percentile of its own 44-quarter history (min 0.8, median 2.0, max 65.8; quarters with earnings only).

Fiscal years

Fiscal year20192020202120222023202420252026
Revenue9.7 bn10.0 bn14.6 bn17.2 bn17.4 bn14.9 bn18.4 bn23.2 bn
Revenue YoY−12.9%+4.1%+45.6%+17.8%+1.2%−14.5%+23.7%+26.0%
Net income2.2 bn2.3 bn3.9 bn4.6 bn4.5 bn3.8 bn5.4 bn7.3 bn
Net income YoY−7.9%+2.8%+73.6%+17.8%−2.0%−15.1%+40.0%+35.6%
Diluted EPS13.7015.1026.9032.753.322.904.155.76
Diluted EPS YoY+4.0%+10.2%+78.1%+21.7%−89.9%−12.7%+43.1%+38.8%
net %22.7%22.4%26.7%26.7%25.9%25.7%29.1%31.3%
Free cash flow2.9 bn1.9 bn3.2 bn2.6 bn4.7 bn4.3 bn5.4 bn4.9 bn

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2026 · 28 Jun 2026

Cash
5.6 bn USD
Financial debt
3.7 bn USD
Net debt
-1.9 bn USD
Equity
12.5 bn USD
Total assets
23.5 bn USD
Debt / equity
0.30x
Current ratio
2.63x
ROE
65.1%
ROA
32.4%
FCF margin
21.1%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2024
14.9 bn
2025
18.4 bn
2026
23.2 bn

SEC (XBRL)· 07 Aug 2026verified

Cost of revenue
2024
7.9 bn
2025
9.5 bn
2026
11.5 bn

SEC (XBRL)· 07 Aug 2026verified

Gross profit
2024
7.1 bn
2025
9.0 bn
2026
11.7 bn

SEC (XBRL)· 07 Aug 2026verified

Research & development
2024
1.9 bn
2025
2.1 bn
2026
2.4 bn

SEC (XBRL)· 07 Aug 2026verified

SG&A
2024
868.2 m
2025
981.7 m
2026
1.1 bn

SEC (XBRL)· 07 Aug 2026verified

Operating income
2024
4.3 bn
2025
5.9 bn
2026
8.2 bn

SEC (XBRL)· 07 Aug 2026verified

Depreciation & amortisation
2024
359.7 m
2025
386.3 m
2026
441.5 m

SEC (XBRL)· 07 Aug 2026verified

EBITDA
2024
4.6 bn ≈
2025
6.3 bn ≈
2026
8.6 bn ≈

SEC (XBRL)· 07 Aug 2026derived

Interest expense
2024
185.2 m
2025
178.2 m
2026
156.9 m

SEC (XBRL)· 07 Aug 2026verified

Pre-tax income
2024
4.4 bn
2025
6.0 bn
2026
8.3 bn

SEC (XBRL)· 07 Aug 2026verified

Income tax
2024
532.5 m
2025
599.9 m
2026
997.1 m

SEC (XBRL)· 07 Aug 2026verified

Net income
2024
3.8 bn
2025
5.4 bn
2026
7.3 bn

SEC (XBRL)· 07 Aug 2026verified

Diluted EPS
2024
2.90
2025
4.15
2026
5.76

SEC (XBRL)· 07 Aug 2026verified

Weighted average diluted shares
2024
1.3 bn
2025
1.3 bn
2026
1.3 bn

SEC (XBRL)· 07 Aug 2026verified

Dividend per share
2024
0.80
2025
0.92
2026
1.04

SEC (XBRL)· 07 Aug 2026verified

Balance sheet · USD

Cash
2024
5.8 bn
2025
6.4 bn
2026
5.6 bn

SEC (XBRL)· 07 Aug 2026verified

Receivables
2024
2.5 bn
2025
3.4 bn
2026
5.3 bn

SEC (XBRL)· 07 Aug 2026verified

Inventories
2024
4.2 bn
2025
4.3 bn
2026
4.3 bn

SEC (XBRL)· 07 Aug 2026verified

Current assets
2024
12.9 bn
2025
14.5 bn
2026
15.6 bn

SEC (XBRL)· 07 Aug 2026verified

Property, plant & equipment, net
2024
2.1 bn
2025
2.4 bn
2026
2.9 bn

SEC (XBRL)· 07 Aug 2026verified

Goodwill
2024
1.6 bn
2025
1.6 bn
2026
1.6 bn

SEC (XBRL)· 07 Aug 2026verified

Intangibles (excl. goodwill)
2024
138.5 m
2025
182.2 m
2026
269.3 m

SEC (XBRL)· 07 Aug 2026verified

Total assets
2024
18.7 bn
2025
21.3 bn
2026
23.5 bn

SEC (XBRL)· 07 Aug 2026verified

Accounts payable
2024
614.0 m
2025
854.2 m
2026
1.3 bn

SEC (XBRL)· 07 Aug 2026verified

Short-term debt
2024
501.3 m
2025
749.7 m
2026
147.0 k

SEC (XBRL)· 07 Aug 2026verified

Long-term debt
2024
4.5 bn
2025
3.7 bn
2026
3.7 bn

SEC (XBRL)· 07 Aug 2026verified

Current liabilities
2024
4.3 bn
2025
6.6 bn
2026
5.9 bn

SEC (XBRL)· 07 Aug 2026verified

Total liabilities
2024
10.2 bn
2025
11.5 bn
2026
11.1 bn

SEC (XBRL)· 07 Aug 2026verified

Equity
2024
8.5 bn †
2025
9.9 bn †
2026
12.5 bn †

SEC (XBRL)· 07 Aug 2026verified

Cash flow · USD

Operating cash flow
2024
4.7 bn
2025
6.2 bn
2026
5.9 bn

SEC (XBRL)· 07 Aug 2026verified

Capex
2024
396.7 m
2025
759.2 m
2026
966.4 m

SEC (XBRL)· 07 Aug 2026verified

Free cash flow
2024
4.3 bn ≈
2025
5.4 bn ≈
2026
4.9 bn ≈

SEC (XBRL)· 07 Aug 2026derived

Investing cash flow
2024
-370.6 m
2025
-708.1 m
2026
-922.2 m

SEC (XBRL)· 07 Aug 2026verified

Financing cash flow
2024
-4.0 bn
2025
-4.9 bn
2026
-5.7 bn

SEC (XBRL)· 07 Aug 2026verified

Dividends paid
2024
1.0 bn
2025
1.1 bn
2026
1.3 bn

SEC (XBRL)· 07 Aug 2026verified

Share repurchases
2024
2.8 bn
2025
3.4 bn
2026
3.9 bn

SEC (XBRL)· 07 Aug 2026verified

Computed indicators

Growth

Revenue growth (YoY)
26.0%
computed by olivLawFY 2026
Revenue CAGR 3Y
10.1%
computed by olivLawFY 2023 → FY 2026
Revenue CAGR 5Y
9.7%
computed by olivLawFY 2021 → FY 2026
EBIT growth (YoY)
39.0%
computed by olivLawFY 2026
Net income growth (YoY)
35.6%
computed by olivLawFY 2026
Net income CAGR 3Y
17.2%
computed by olivLawFY 2023 → FY 2026
Net income CAGR 5Y
13.2%
computed by olivLawFY 2021 → FY 2026
EPS growth (YoY)
38.8%
computed by olivLawFY 2026
EPS CAGR 3Y
20.2%
computed by olivLawFY 2023 → FY 2026
EPS CAGR 5Y
-26.5%
computed by olivLawFY 2021 → FY 2026
FCF growth (YoY)
-9.7%
computed by olivLawFY 2026

Profitability

Gross margin
51.1%
computed by olivLawTTM to 27 Sept 2026
EBITDA margin
38.7%
computed by olivLawTTM to 27 Sept 2026
EBIT margin
37.0%
computed by olivLawTTM to 27 Sept 2026
Net margin
32.3%
computed by olivLawTTM to 27 Sept 2026
FCF margin
25.0%
computed by olivLawTTM to 27 Sept 2026

Returns

ROE
70.1%
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
ROA
35.0%
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
ROIC
156.5%
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
ROCE
50.7%
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
Payout ratio (EPS)
16.5%
computed by olivLawTTM to 27 Sept 2026
Payout ratio (FCF)
19.9%
computed by olivLawTTM to 27 Sept 2026

Balance sheet

Net debt
-7.4 bn USD
computed by olivLawbalance sheet at 27 Sept 2026
Net debt / EBITDA
-0.7x
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
Debt / equity
0.0x
computed by olivLawbalance sheet at 27 Sept 2026
Interest coverage
63.9x
computed by olivLawTTM to 27 Sept 2026

Liquidity

Current ratio
2.5x
computed by olivLawbalance sheet at 27 Sept 2026
Quick ratio
1.9x
computed by olivLawbalance sheet at 27 Sept 2026
Cash ratio
1.0x
computed by olivLawbalance sheet at 27 Sept 2026

Cash

Operating cash flow
7.6 bn USD
computed by olivLawTTM to 27 Sept 2026
Capital expenditure
1.0 bn USD
computed by olivLawTTM to 27 Sept 2026
Free cash flow
6.5 bn USD
computed by olivLawTTM to 27 Sept 2026
FCF conversion
77.4%
computed by olivLawTTM to 27 Sept 2026
Cash conversion
74.9%
computed by olivLawTTM to 27 Sept 2026

Efficiency

Days sales outstanding
65 days
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
Days inventory outstanding
137 days
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
Days payables outstanding
39 days
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
Cash conversion cycle
163 days
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026

Market and valuation

Market capitalisation
288.2 bn USD
computed by olivLawbalance sheet at 27 Sept 2026
Enterprise value
280.8 bn USD
computed by olivLawbalance sheet at 27 Sept 2026
Market cap / net income TTM
34.1x
computed by olivLawTTM to 27 Sept 2026
P/E (TTM)
34.4x
computed by olivLawTTM to 27 Sept 2026
Earnings yield
2.9%
computed by olivLawTTM to 27 Sept 2026
P/B
20.7x
computed by olivLawbalance sheet at 27 Sept 2026
P/S
11.0x
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
EV/EBITDA
27.8x
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
EV/EBIT
29.1x
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
EV/Sales
10.7x
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
P/FCF
44.1x
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
FCF yield
2.3%
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
Dividend yield
0.5%
computed by olivLawTTM to 27 Sept 2026
Shareholder yield (distributions)
1.8%
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026

Risk

Altman Z
18.57
computed by olivLawbalance sheet at 27 Sept 2026

Valuation

olivLaw classification

Neutral profile

Score: 69 / 100

A scoring methodology on indicators and valuation, not investment advice.

Closing price

230.72 USD

03 Nov 2026Source: olivLaw, closing series

Market cap: 288.2 bn USD

Key indicators

Market capitalisation
288.2 bn USD
computed by olivLawbalance sheet at 27 Sept 2026
P/E (TTM)
34.4x
computed by olivLawTTM to 27 Sept 2026
P/B
20.7x
computed by olivLawbalance sheet at 27 Sept 2026
EV/EBITDA
27.8x
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
ROE
70.1%
computed by olivLawTTM to 27 Sept 2026 · balance sheet at 27 Sept 2026
Net margin
32.3%
computed by olivLawTTM to 27 Sept 2026
Revenue growth (YoY)
26.0%
computed by olivLawFY 2026
Dividend yield
0.5%
computed by olivLawTTM to 27 Sept 2026

Coverage and freshness

36/37 reporting lines present
Latest full fiscal year: 2026
Latest reported period: 27 Sept 2026
Latest balance sheet date: 27 Sept 2026
Share count (cover of the latest filing), as of: 20 Oct 2026
Source: SEC (XBRL)published 22 Oct 2026
verified 2932derived 270

Score by group

  • Valuation21
  • Returns55
  • Quality89
  • Balance sheet100
  • Growth92

Estimated value range

Low
113.01
USD per share
Mid
138.00
USD per share
High
175.36
USD per share
Price: 230.72 USD
The price is above the range
Potential to the central value: -40.2% (value / price − 1)
Margin of safety: -67.2% (1 − price / value)
Agreement between methods: low · 2 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 85.13 – 224.37 USD.

Methods computed but outside the aggregate range: Dividend discount (DDM) (a small share of earnings is paid as dividends (capital returns through buybacks): the dividend model does not describe the value and stays outside the aggregate).

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)85.13 – 126.36 (Mid 101.23)
    WACC 9.3% · starting FCFF 6.7 bn USD · terminal value share of EV 73%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: no growth between −30% and +40% justifies the price
  • Peers: EV/EBITDAunavailable · not enough peers
  • Peers: P/E140.90 – 224.37 (Mid 174.77)
    7 companies used · median multiple 26.0x · quartiles 21.0x – 33.4x
    ACLS, ACMR, ASYS, CRCT, CVV, ERII, SOTK
  • Dividend discount (DDM)outside the aggregate13.67 – 18.38 (Mid 15.68)
    a small share of earnings is paid as dividends (capital returns through buybacks): the dividend model does not describe the value and stays outside the aggregate
Multiple comparisons use the SIC vertical: Special Industry Machinery, NEC (SIC 3559)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Neutral profile · Score 69/100

FactorValueScoreWeight used
ROIC · Quality156.5%100 (vs peers)10%
Net margin · Quality32.3%92 (vs peers)6%
FCF conversion · Quality77.4%68 (on a fixed band)6%
Revenue CAGR 3Y · Growth10.1%84 (on a fixed band)8%
EPS CAGR 3Y · Growth20.2%100 (on a fixed band)8%
Net debt / EBITDA · Balance sheet-0.7x100 (on a fixed band)10%
Interest coverage · Balance sheet63.9x100 (on a fixed band)6%
Current ratio · Balance sheet2.5x100 (on a fixed band)4%
P/E (TTM) · Valuation34.4x38 (vs peers)10%
EV/EBITDA · Valuation27.8x0 (on a fixed band)10%
FCF yield · Valuation2.3%28 (on a fixed band)8%
Shareholder yield (distributions) · Returns1.8%26 (on a fixed band)6%
Payout ratio (FCF) · Returns19.9%100 (on a fixed band)4%

Score groups

  • Balance sheet100/100 · 3/3 factors with a value
  • Growth92/100 · 2/2 factors with a value
  • Quality89/100 · 3/3 factors with a value
  • Returns55/100 · 2/2 factors with a value
  • Valuation21/100 · 3/3 factors with a value

Memo

LAM RESEARCH CORPORATION (LRCX). Latest full fiscal year: 2026; data up to 2026-09-27.

Figures computed from the financial statements: revenue 23.2 bn USD in 2026; YoY growth 26.0%; net margin 32.3%; ROE 70.1%; net debt/EBITDA -0.7x.

The estimated value range is 113.01–175.36 USD per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 138.00 USD, the price of 230.72 USD leaves a potential of -40.2% (value / price − 1) and a margin of safety of -67.2% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 69/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • ROIC: 156.5%
  • Net margin: 32.3%
  • Revenue CAGR 3Y: 10.1%
  • EPS CAGR 3Y: 20.2%
  • Net debt / EBITDA: -0.7x
  • Interest coverage: 63.9x
  • Current ratio: 2.5x
  • Payout ratio (FCF): 19.9%

What contradicts it

  • EV/EBITDA: 27.8x
  • FCF yield: 2.3%
  • Shareholder yield (distributions): 1.8%
  • The price is above the estimated value range
  • The valuation methods diverge

Versus the vertical median

Special Industry Machinery, NEC (SIC 3559) · same industry (4-digit SIC) · compared with 12 companies

The size band was not applied: too few companies would have remained; the vertical includes much smaller or larger companies.

Multiples and returns vs the median

P/E
34.4x
vertical median 28.5x
above median (+20.8%)
EV/EBITDA
27.8x
vertical median 14.6x
above median (+89.8%)
P/S
11.0x
vertical median 2.8x
above median (+294.9%)
P/B
20.7x
vertical median 1.9x
above median (+1,007.9%)
ROE
70.1%
vertical median 8.7%
above median (+703.0%)
Net margin
32.3%
vertical median 10.0%
above median (+222.9%)
EBIT margin
37.0%
vertical median 9.2%
above median (+303.2%)
Revenue YoY
26.0%
vertical median 0.7%
above median (+3,495.4%)
Net debt/EBITDA
-0.7x
vertical median -2.5x
above median
Dividend yield
0.5%
vertical median —

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
LRCXLam Research Corporation288.2 bn34.470.1%32.3%+26.0%+43% / +264%
ACLSAxcelis Technologies Inc2.8 bn30.98.9%10.7%−17.6%+11% / −26%
VECOVeeco Instruments Inc2.2 bn100.52.6%3.4%−7.4%+23% / +26%
CRCTCricut, Inc.1.9 bn20.925.9%12.7%−0.5%+87% / +29%
AZTAAzenta, Inc.1.7 bn—-7.7%-20.0%+3.6%+10% / −31%
ACMRACM Research, Inc.629.9 m21.010.6%14.5%+15.2%+33% / +167%
ERIIEnergy Recovery, Inc.366.0 m26.08.6%12.7%−6.9%−50% / −62%
ASYSAmtech Systems, Inc.216.2 m46.74.8%4.9%−21.6%+57% / +60%
VELOVelo3D, Inc.181.5 m—-61.5%-89.6%+12.1%+6% / −99%
SOTKSono Tek Corp71.0 m36.010.1%9.3%+2.0%+24% / −10%
TRTTrio-Tech International51.5 m—-0.1%-0.1%+71.6%+16% / +103%
CVVCvd Equipment Corporation26.8 m2.732.7%62.0%−4.1%+10% / −19%
ASMLAsml Holding NV——50.5%29.4%+15.6%+41% / +119%

1- and 3-year price returns: for LRCX from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
145.09
Total return -37% · Per year -37%
255.86
Total return 11% · Per year 11%
384.51
Total return 67% · Per year 67%
3 years
156.98
Total return -31% · Per year -12%
309.91
Total return 36% · Per year 11%
509.01
Total return 123% · Per year 31%
5 years
169.84
Total return -24% · Per year -5%
375.37
Total return 66% · Per year 11%
673.82
Total return 196% · Per year 24%
What moves the 3-year price the most
  • Exit P/E± 77.48
  • Net margin± 54.23
  • Annual revenue growth± 42.27
  • Annual dilution± 4.56

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Lam Research is a global supplier of wafer fabrication equipment spanning deposition, etch and clean. Revenue in fiscal 2026 reached 23.23 billion USD, up 26.0%, supported by demand linked to artificial intelligence 1. In the quarter ended September 27, 2026, revenue was 8.22 billion USD 23.

SWOT

Strengths

  • Strong position in deposition, etch and clean, with a large installed base that generates recurring support revenue.
  • High gross margins and accelerating profitability in the period reviewed, supported by a favourable customer mix.
  • Sustained investment in research and development, which helps keep access to new process technologies.

Weaknesses

  • Heavy reliance on a few regions, notably China and Taiwan, exposes the company to geopolitical and regulatory risk.
  • Revenue is cyclical and can fall sharply when customers cut capacity investment.
  • Personnel and research costs have risen with team expansion, which could weigh on margins if demand declines.

Opportunities

  • Demand linked to artificial intelligence and advanced memory could support growth in new systems and services.
  • The shift to 3D and gate-all-around architectures could increase the need for precise etch and deposition processes.
  • Expanding the offer for advanced packaging and HBM integration could open new revenue segments.

Threats

  • Export restrictions and tariffs may limit access to certain markets and raise production costs.
  • State-financed competitors and customers building their own equipment could reduce market share.
  • A slowdown in chip demand could lead to delays or cancellations of equipment orders.

Risks

  • Rapid technological changehigh

    If new products are not delivered on time or do not meet required performance, the company could lose market share and hold obsolete inventory 1.

  • Intense competitionhigh

    Rivals with greater resources could offer comparable products or price cuts, which could hurt sales 1.

  • Cyclicality of investmentmedium

    Sudden shifts in customers' investment plans can affect demand and create fixed-cost sizing problems 1.

  • Trade restrictions and export controlshigh

    New restrictions or tariffs could limit sales in certain countries and raise component costs 12.

  • Supply chainmedium

    Supply chain disruptions or capacity limits could delay deliveries and affect revenue 3.

Investment thesis

What would need to be true (bull case)

  • Rapid growth in revenue and earnings per share shows that demand for advanced equipment remains strong, and AI investment could sustain this trend.
  • A large share of services and the installed base offers a steadier revenue stream than new equipment sales alone.
  • Guidance for the next quarter points to continued growth, which could confirm that the upward trend is sustained.

What would break the thesis

  • Revenue depends heavily on chip investment, which is known to be cyclical, and a fall in demand could quickly reduce results.
  • High exposure to China and export restrictions could limit growth and add long-term uncertainty.
  • State-backed competitors and customers building their own equipment could reduce the company's share, especially if prices fall.

What to watch

  • Financial results and delivery against guidance for the quarter ending December 27, 2026Q2 2027
  • Trend in China's share of revenue and the effect of export restrictionsQ2 2027
  • Dynamics of memory demand and foundry investment linked to AI2027

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Lam Research Corporation, incorporated in 1980 and headquartered in Fremont, California, designs and sells wafer fabrication equipment for the semiconductor industry 1. Its customers are memory, foundry and integrated device manufacturers producing NVM, DRAM and logic devices 1. The company also offers services for installed equipment, including spares, upgrades and the Reliant line of non-leading-edge products 1.

Revenue splits between new systems, which reached 14.89 billion USD in fiscal 2026, and customer support revenue of 8.35 billion USD 1. This structure gives the company an installed base that generates recurring revenue outside the investment cycles of its customers. Research and development represented 10.2% of revenue in fiscal 2026 1.

Segments

Deposition, etch and clean

The company has product lines for metal and dielectric deposition, conductor, dielectric and selective etch, and wet and dry cleaning 1. The ALTUS, SABRE, Akara, Kiyo and Vantex families are examples cited in the annual report 1. Each category addresses a different stage of chip manufacturing.

Market context

Over the longer term, the company's view is that semiconductor demand, together with 3D scaling and advanced integration, could support growth in its served market 12. The main risk remains volatility from trade restrictions, tariffs and export controls 2.

Trends

  • Demand driven by artificial intelligencetailwind

    AI infrastructure is boosting investment in advanced memory and logic, and quarterly revenue has grown rapidly 12. If demand stays high, it could support margins and volumes.

  • Shift to 3D and gate-all-around architecturestailwind

    The move from FinFET to gate-all-around and from planar to 3D memory raises the complexity of etch and deposition steps 1. This favours the company's advanced equipment, though it requires large research spending.

  • Trade restrictions and tariffsheadwind

    Export controls, tariffs and trade disputes could limit sales to certain customers and raise procurement costs 12. The company has already reported a margin impact from tariff-related spending on aluminium and steel 1.

  • Industry consolidation and regional competitorsmixed

    Emerging regional competitors, some state-backed, and customer consolidation could reduce market share 1. Some customers have set up affiliated entities that build similar equipment 1.

Competitive position

Lam Research operates in a competitive environment where rivals, some financed by foreign governments, have larger financial resources 1. They may offer broader product portfolios or discount aggressively 1. Once a customer commits to a competitor's equipment for a product line, it becomes harder for the company to win that customer back 1.

The company says it differentiates through research, learning from its installed base and integrated multi-product solutions 1. It also relies on close collaboration with customers and ecosystem partners 1. Competitive pressure could increase if new rivals gain access to critical technology 1.

  • Applied MaterialsAMAT

    Named indirectly in the context of competitive pressure in semiconductor equipment; the sources provided give no quantitative detail.

  • Tokyo Electron

    Japanese equipment maker that could compete in deposition and etch segments; the sources give no detail on its share.

  • State-backed regional competitors

    Companies in jurisdictions with a more favourable legal framework that can sell in areas restricted for Lam and compete on price.

  • Customers with in-house equipment entities

    Some customers have created affiliated entities that build similar equipment, which amounts to competition.

News & filings

In the press

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2026-06-28 · SEC / Lam Research Corporation · 07 Aug 2026
  2. [2] Form 10-Q, quarter ended 2026-09-27 · SEC / Lam Research Corporation · 22 Oct 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / Lam Research Corporation · 21 Oct 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.